
![]() |
Shengkan (Victor)
Jin, Ph.D. RWJMS/Piscataway
R529 |
| Research Interests: |
Autophagy in cancer biology, cancer therapy, and aging control
| Research Summary: |
Humans, as well as other mammals with long life spans, face a formidable challenge: the accumulation of somatic mutations over time. These mutations often manifest themselves in various diseases, which eventually lead to the demise of the individual organism. Cancer is one of these diseases, which is caused by a combination of somatic genetic changes in a single cell that together result in uncontrolled cell growth and proliferation. In essence, cancer is an aging disease. It is not surprising that age is the single most important risk factor of cancer and many cellular processes are involved in both aging control and tumor suppression. The laboratory is focused on autophagy, an incredible new cellular process that we and others have demonstrated to play a critical role in preventing both cancer development and aging.
Autophagy is a higly regulated membrane-trafficking process leading to the lysosomal degradation (as shown in the inserted figure). During autophagy, cytoplasmic components are first sequestered in double-membrane vesicles--the autophagic vacuoles or autophagosomes. These vesicles then dock and fuse to lysosomes, where they are further degraded. It is believed that autophagic degradation plays a critical role for clearing damaged organelles and protein aggregates and is essential for the maintenance of a health cell.
The genes involved in autophagy, known as the autophagy-related genes (Atg), have been identified and characterized. The first autophagy gene in humans identified was named Beclin 1. Interestingly, Knocking out Beclin1 gene in mice increases cancer rates. Similarly, in humans Beclin 1 is monoallelically deleted in up to 40% of prostate cancers, 50% of breast cancers, and 75% of ovarian cancers. Part of the laboratory is working on the mechanism by which autophagy defect causes cancer. In addition, the lab is also working on pharmacologically manipulating autophagy in normal and cancer cells for tumor prevention and tumor therapy.
Autophagy is also involved in aging control. Inactivation of the beclin1 gene or other autophagy genes in C. elegans would reduce the life-spans of the worms. Apparently mitochondria, the organelles that are the major sources of intracellular reactive oxygen species (ROS) and are known to be a major contributor to aging, can only be degraded through autophagy. Part of the lab is working on how autophagy specifically degrades damaged mitochondria and how that would impact aging.
The research conducted in the lab is supported by the National Cancer Institute (NCI) and National Institute of Aging (NIA) of NIH, American Cancer Society (ACS), and the Department of Defense.
| Laboratory Personnel: |
| Selected Publications |
| Lab Positions Available: |
The lab has several positions available for motivated postdoctoral fellow, technician, and graduate student.